ProteaseTag® Active Neutrophil Elastase Immunoassay

About ProAxsis

ProAxsis is a UK-based diagnostics company focused on the respiratory disease market. Its core innovation is the ProteaseTag® platform, which enables the specific detection of active protease enzymes, offering a potential 'gold standard' over traditional assays that measure total protein. The company has commercialized several immunoassays and offers contract services, positioning itself as a partner for pharmaceutical development and clinical research in conditions like COPD and cystic fibrosis. It is a portfolio company of the investment group NetScientific plc.

Therapeutic Areas